A list of downloadable documents created during development.
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in early breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: third diagnostics consultation document - equality impact assessment - guidance
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in early breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: third diagnostics consultation document - comments and response
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in early breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: second diagnostics consultation document - comments and response
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in early breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: first diagnostics consultation document - comments and response
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in early breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: diagnostics consultation 3
GEP and IHC tests for breast cancer assessment: confirmed public minutes 9 January 2013
Gene expression profiling and expanded immunohistochemistry tests to guide the use of adjuvant chemotherapy in breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: diagnostics consultation 2
GEP and IHC tests for breast cancer assessment & SeHCAT: confirmed public minutes 4 September 2012
Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: diagnostics consultation
Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: Diagnostics Assessment Report
Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: appendices to the Diagnostics Assessment Report
Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: Stakeholder comments and External Assessment Group responses
Gene expression profiling and expanded immunohistochemistry tests to guide selection of chemotherapy regimes in breast cancer management - MammaPrint, Oncotype DX, IHC4 and Mammostrat: overview
GEP and IHC tests for breast cancer assessment: minutes 4 January 2012
GEP and IHC tests for breast cancer assessment: amended final scope
GEP and IHC tests for breast cancer assessment: list of specialists committee members
GEP and IHC tests for breast cancer assessment: final protocol
GEP and IHC tests for breast cancer assessment: final scope